Inify Laboratories AB
INIFY | ST
Overview
Corporate Details
- ISIN(s):
- SE0017486103
- LEI:
- 549300306YYJ3BX3VB98
- Country:
- Sweden
- Address:
- Scheeles väg 3, 171 65 Solna
- Website:
- https://www.inify.com/
- Sector:
- Human health and social work activities
- Industry:
- Other human health activities
Description
Inify Laboratories AB provides cancer diagnostics through ultramodern laboratory services within pathology. The company operates a fully digital, standardized, and AI-supported workflow designed to optimize diagnostic quality and significantly reduce turnaround times for biopsy results. Initially specializing in prostate cancer diagnostics with its "Inify Prostate" decision support tool, the company has achieved a significant market share in Stockholm and is expanding into other areas, such as gastrointestinal diagnostics. Inify Laboratories serves healthcare providers and is undergoing international expansion, including into the UK market.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Inify Laboratories AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-21 08:00 |
Post-Annual General Meeting Information
Inify Laboratories AB (publ) – summary of Annual General Meeting
|
English | 180.9 KB | |
| 2025-05-21 08:00 |
Post-Annual General Meeting Information
Inify Laboratories AB (publ) – kommuniké från årsstämma
|
Swedish | 172.6 KB | |
| 2025-05-21 06:00 |
Post-Annual General Meeting Information
Inify Laboratories AB (publ) - summary of Annual General Meeting
|
English | 180.9 KB | |
| 2025-05-21 06:00 |
Post-Annual General Meeting Information
Inify Laboratories AB (publ) - kommuniké från årsstämma
|
Swedish | 172.6 KB | |
| 2025-05-21 06:00 |
Post-Annual General Meeting Information
Inify Laboratories AB (publ) - summary of Annual General Meeting
|
English | 3.4 KB | |
| 2025-05-21 06:00 |
Post-Annual General Meeting Information
Inify Laboratories AB (publ) - kommuniké från årsstämma
|
Swedish | 3.4 KB | |
| 2025-04-30 08:00 |
Quarterly Report
|
Swedish | 1.3 MB | |
| 2025-04-30 08:00 |
Quarterly Report
|
English | 1.3 MB | |
| 2025-04-30 06:00 |
Quarterly Report
Inify Laboratories: Continued strong growth - construction and establishment in…
|
English | 1.3 MB | |
| 2025-04-30 06:00 |
Quarterly Report
Inify Laboratories: Fortsatt stark tillväxt - uppbyggnad och etablering i Storb…
|
Swedish | 1.3 MB | |
| 2025-04-30 06:00 |
Quarterly Report
Inify Laboratories: Fortsatt sterk vekst - bygging og etablering i Storbritannia
|
English | 1.3 MB | |
| 2025-04-30 06:00 |
Earnings Release
Inify Laboratories: Continued strong growth - construction and establishment in…
|
English | 3.4 KB | |
| 2025-04-30 06:00 |
Earnings Release
Inify Laboratories: Fortsatt stark tillväxt - uppbyggnad och etablering i Storb…
|
Swedish | 3.4 KB | |
| 2025-04-30 06:00 |
Earnings Release
Inify Laboratories: Fortsatt sterk vekst - bygging og etablering i Storbritannia
|
Norwegian | 3.3 KB | |
| 2025-04-16 06:00 |
Annual Report
Inify Laboratories - Årsredovisning 2024
|
Swedish | 3.1 MB |
Automate Your Workflow. Get a real-time feed of all Inify Laboratories AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Inify Laboratories AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-29 | Olof Sandén | Other | Buy | 10,000 | 44,800.00 SEK |
| 2025-01-27 | Olof Sandén | Other | Buy | 6,840 | 28,659.60 SEK |
| 2023-07-05 | Magne Jordanger | Other | Buy | 650,000 | 6,500,000.00 EUR |
| 2022-08-19 | Magne Jordanger | Other | Buy | 336,950 | 2,560,820.00 EUR |
